94 related articles for article (PubMed ID: 7930741)
1. Strong IgG isotypic antibody response in sowdah type onchocerciasis.
Brattig NW; Krawietz I; Abakar AZ; Erttmann KD; Kruppa TF; Massougbodji A
J Infect Dis; 1994 Oct; 170(4):955-61. PubMed ID: 7930741
[TBL] [Abstract][Full Text] [Related]
2. Humoral responses to a secretory Onchocerca volvulus protein: differences in the pattern of antibody isotypes to recombinant Ov20/OvS1 in generalized and hyperreactive onchocerciasis.
Mpagi JL; Büttner DW; Tischendorf FW; Erttmann KD; Brattig NW
Parasite Immunol; 2000 Sep; 22(9):455-60. PubMed ID: 10972852
[TBL] [Abstract][Full Text] [Related]
3. The profile of IgG and IgG subclasses of onchocerciasis patients.
Dafa'alla TH; Ghalib HW; Abdelmageed A; Williams JF
Clin Exp Immunol; 1992 May; 88(2):258-63. PubMed ID: 1572089
[TBL] [Abstract][Full Text] [Related]
4. Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology.
Murdoch ME; Abiose A; Garate T; Hay RJ; Jones BR; Maizels RM; Parkhouse RM
Am J Trop Med Hyg; 1996 Jun; 54(6):600-12. PubMed ID: 8686779
[TBL] [Abstract][Full Text] [Related]
5. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens.
Boyer AE; Tsang VC; Eberhard ML; Zea-Flores G; Hightower A; Pilcher JB; Zea-Flores R; Zhou W; Reimer CB
J Immunol; 1991 Jun; 146(11):4001-10. PubMed ID: 2033268
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of immunoglobulin G antibodies against Onchocerca volvulus excretory-secretory antigens in different forms and stages of onchocerciasis.
Wanni NO; Strote G; Rubaale T; Brattig NW
Trans R Soc Trop Med Hyg; 1997; 91(2):226-30. PubMed ID: 9196778
[TBL] [Abstract][Full Text] [Related]
8. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
9. Isotype-specific characterization of antibody responses to Onchocerca volvulus in putatively immune individuals.
Stewart GR; Elson L; Araujo E; Guderian R; Nutman TB; Bradley JE
Parasite Immunol; 1995 Jul; 17(7):371-80. PubMed ID: 8552410
[TBL] [Abstract][Full Text] [Related]
10. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
[TBL] [Abstract][Full Text] [Related]
11. Onchocerca ochengi acquisition in zebu Gudali cattle exposed to natural transmission: parasite population dynamics and IgG antibody subclass responses to Ov10/Ov11 recombinant antigens.
Achukwi MD; Harnett W; Bradley J; Renz A
Vet Parasitol; 2004 Jun; 122(1):35-49. PubMed ID: 15158555
[TBL] [Abstract][Full Text] [Related]
12. Analysis of IgG isotype responses against Onchocerca volvulus antigens in children in an onchocerciasis-endemic area in northern Nigeria.
Enwezor FN; Nock IH; Edeghere H; Idowu BT; Osue HO; Engelbrecht F
Ann Trop Paediatr; 2000 Jun; 20(2):141-6. PubMed ID: 10945066
[TBL] [Abstract][Full Text] [Related]
13. Human isotype antibody responses to an Onchocerca volvulus glutathione S-transferase.
Salinas G; Sinha K; Cooper JP; Whitworth JA; Taylor DW
Parasite Immunol; 1996 Aug; 18(8):377-86. PubMed ID: 9229391
[TBL] [Abstract][Full Text] [Related]
14. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
15. Guatemalan human onchocerciasis. I. Systematic analysis of patient populations, nodular antigens, and specific isotypic reactions.
Tsang VC; Boyer AE; Pilcher JB; Eberhard ML; Reimer CB; Zea-Flores G; Zea-Flores R; Zhou W; Richards FO
J Immunol; 1991 Jun; 146(11):3993-4000. PubMed ID: 2033267
[TBL] [Abstract][Full Text] [Related]
16. Immune recognition of Onchocerca volvulus proteins in the human host and animal models of onchocerciasis.
Manchang TK; Ajonina-Ekoti I; Ndjonka D; Eisenbarth A; Achukwi MD; Renz A; Brattig NW; Liebau E; Breloer M
J Helminthol; 2015 May; 89(3):375-86. PubMed ID: 24721822
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.
Gómez-Priego A; Mendoza R; de-la-Rosa JL
Clin Diagn Lab Immunol; 2005 Jan; 12(1):40-3. PubMed ID: 15642982
[TBL] [Abstract][Full Text] [Related]
18. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states.
Brattig N; Nietz C; Hounkpatin S; Lucius R; Seeber F; Pichlmeier U; Pogonka T
J Infect Dis; 1997 Sep; 176(3):838-42. PubMed ID: 9291349
[TBL] [Abstract][Full Text] [Related]
19. B cell responses to paramyosin. Isotypic analysis and epitope mapping of filarial paramyosin in patients with onchocerciasis.
Steel C; Limberger RJ; McReynolds LA; Ottesen EA; Nutman TB
J Immunol; 1990 Dec; 145(11):3917-23. PubMed ID: 1701001
[TBL] [Abstract][Full Text] [Related]
20. Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.
Cooper PJ; Espinel I; Wieseman M; Paredes W; Espinel M; Guderian RH; Nutman TB
Infect Immun; 1999 Nov; 67(11):5951-7. PubMed ID: 10531253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
